Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064

Expensive Underperformer

Download real time

933.10 0.25 (0.03%)

Near 52W Low of ₹915.75

74,727 NSE+BSE Volume

NSE 08 Aug, 2025 3:31 PM (IST)

23,753.5

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Board Meeting

The next board meeting for Cohance Lifesciences Ltd. is on 13 Aug 2025 for the purpose of Quarterly Results See details

Cohance Lifesciences Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for COHANCE, BSE:543064 Cohance Lifesciences Ltd.

VOTE: Is Suven Pharmaceuticals Ltd. worth buying?

26 Votes:

Buy 69.23%

Sell 11.54%

Hold 19.23%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >